English
简体中文
Total: £ 56.28
Published Date: 2026-04-07 | Pages: 121 | Tables: 127 | Medical Devices & Consumables
The global FPR1 Antibody market was valued at US$ 63.27 million in 2025 and is anticipated to reach US$ 88.14 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on FPR1 Antibody competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
FPR1 antibody is an immunoglobulin directed against FPR1 (Formyl Peptide Receptor 1, N-formyl peptide receptor 1). FPR1 is a G protein-coupled receptor that can recognize and bind chemical substances such as bacterial-derived N-formyl peptide and plays an important role in immune and inflammatory responses. FPR1 antibodies are usually produced by animal immunization and can be used in scientific research to detect, locate and quantify the expression level of FPR1 protein in cells or tissues. The application of this antibody can help researchers better understand the function of FPR1 in biological processes such as inflammation, immune response, cell migration, and its relationship with the occurrence and development of diseases.
FPR1（Formyl Peptide Receptor 1）作为G蛋白偶联受体，在炎症反应、细胞迁移和癌症发展中发挥着重要作用。因此，FPR1抗体在科研和临床应用中的需求逐渐增长，特别是在肿瘤学和免疫学领域。随着生物技术的不断进步，FPR1抗体的制备技术也在提高。高亲和力、高特异性的抗体能够更好地满足科研和临床的需求，推动FPR1抗体市场的快速发展。总的来说，FPR1抗体市场具有广阔的发展前景和巨大的市场潜力。
This report delivers a comprehensive overview of the global FPR1 Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding FPR1 Antibody. The FPR1 Antibody market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global FPR1 Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist FPR1 Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abcam
Cell Signaling Technology
Santa Cruz Biotechnology
Novus Biologicals
Thermo Fisher Scientific
R&D Systems
Sigma-Aldrich
BioLegend
OriGene Technologies
Boster Bio
Proteintech
4a Biotech
Segment by Type
Monoclonal Antibodies
Polyclonal Antibodies
by Application
Immunology Research
Biomedical Research
Drug Discovery
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for FPR1 Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines FPR1 Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 FPR1 Antibody Market Overview
1.1 Product Definition
1.2 FPR1 Antibody by Type
1.2.1 Global FPR1 Antibody Market Value by Type: 2025 vs 2032
1.2.2 Monoclonal Antibodies
1.2.3 Polyclonal Antibodies
1.3 FPR1 Antibody by Application
1.3.1 Global FPR1 Antibody Market Value by Application: 2025 vs 2032
1.3.2 Immunology Research
1.3.3 Biomedical Research
1.3.4 Drug Discovery
1.4 Global FPR1 Antibody Market Size Estimates and Forecasts
1.4.1 Global FPR1 Antibody Revenue 2021–2032
1.4.2 Global FPR1 Antibody Sales 2021–2032
1.4.3 Global FPR1 Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 FPR1 Antibody Market Competition by Manufacturers
2.1 Global FPR1 Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global FPR1 Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global FPR1 Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of FPR1 Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of FPR1 Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of FPR1 Antibody, Product Types and Applications
2.7 Global Key Manufacturers of FPR1 Antibody, Date of Entry into the Industry
2.8 Global FPR1 Antibody Market Competitive Situation and Trends
2.8.1 Global FPR1 Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global FPR1 Antibody Players Market Share by Revenue
2.8.3 Global FPR1 Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global FPR1 Antibody Market Scenario by Region
3.1 Global FPR1 Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global FPR1 Antibody Sales by Region: 2021–2032
3.2.1 Global FPR1 Antibody Sales by Region: 2021–2026
3.2.2 Global FPR1 Antibody Sales by Region: 2027–2032
3.3 Global FPR1 Antibody Revenue by Region: 2021–2032
3.3.1 Global FPR1 Antibody Revenue by Region: 2021–2026
3.3.2 Global FPR1 Antibody Revenue by Region: 2027–2032
3.4 North America FPR1 Antibody Market Facts & Figures by Country
3.4.1 North America FPR1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America FPR1 Antibody Sales by Country (2021–2032)
3.4.3 North America FPR1 Antibody Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe FPR1 Antibody Market Facts & Figures by Country
3.5.1 Europe FPR1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe FPR1 Antibody Sales by Country (2021–2032)
3.5.3 Europe FPR1 Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific FPR1 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific FPR1 Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific FPR1 Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific FPR1 Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America FPR1 Antibody Market Facts & Figures by Country
3.7.1 Latin America FPR1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America FPR1 Antibody Sales by Country (2021–2032)
3.7.3 Latin America FPR1 Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa FPR1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa FPR1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa FPR1 Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa FPR1 Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global FPR1 Antibody Sales by Type (2021–2032)
4.1.1 Global FPR1 Antibody Sales by Type (2021–2026)
4.1.2 Global FPR1 Antibody Sales by Type (2027–2032)
4.1.3 Global FPR1 Antibody Sales Market Share by Type (2021–2032)
4.2 Global FPR1 Antibody Revenue by Type (2021–2032)
4.2.1 Global FPR1 Antibody Revenue by Type (2021–2026)
4.2.2 Global FPR1 Antibody Revenue by Type (2027–2032)
4.2.3 Global FPR1 Antibody Revenue Market Share by Type (2021–2032)
4.3 Global FPR1 Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global FPR1 Antibody Sales by Application (2021–2032)
5.1.1 Global FPR1 Antibody Sales by Application (2021–2026)
5.1.2 Global FPR1 Antibody Sales by Application (2027–2032)
5.1.3 Global FPR1 Antibody Sales Market Share by Application (2021–2032)
5.2 Global FPR1 Antibody Revenue by Application (2021–2032)
5.2.1 Global FPR1 Antibody Revenue by Application (2021–2026)
5.2.2 Global FPR1 Antibody Revenue by Application (2027–2032)
5.2.3 Global FPR1 Antibody Revenue Market Share by Application (2021–2032)
5.3 Global FPR1 Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abcam
6.1.1 Abcam Company Information
6.1.2 Abcam Description and Business Overview
6.1.3 Abcam FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abcam FPR1 Antibody Product Portfolio
6.1.5 Abcam Recent Developments/Updates
6.2 Cell Signaling Technology
6.2.1 Cell Signaling Technology Company Information
6.2.2 Cell Signaling Technology Description and Business Overview
6.2.3 Cell Signaling Technology FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Cell Signaling Technology FPR1 Antibody Product Portfolio
6.2.5 Cell Signaling Technology Recent Developments/Updates
6.3 Santa Cruz Biotechnology
6.3.1 Santa Cruz Biotechnology Company Information
6.3.2 Santa Cruz Biotechnology Description and Business Overview
6.3.3 Santa Cruz Biotechnology FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Santa Cruz Biotechnology FPR1 Antibody Product Portfolio
6.3.5 Santa Cruz Biotechnology Recent Developments/Updates
6.4 Novus Biologicals
6.4.1 Novus Biologicals Company Information
6.4.2 Novus Biologicals Description and Business Overview
6.4.3 Novus Biologicals FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Novus Biologicals FPR1 Antibody Product Portfolio
6.4.5 Novus Biologicals Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Thermo Fisher Scientific FPR1 Antibody Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 R&D Systems
6.6.1 R&D Systems Company Information
6.6.2 R&D Systems Description and Business Overview
6.6.3 R&D Systems FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 R&D Systems FPR1 Antibody Product Portfolio
6.6.5 R&D Systems Recent Developments/Updates
6.7 Sigma-Aldrich
6.7.1 Sigma-Aldrich Company Information
6.7.2 Sigma-Aldrich Description and Business Overview
6.7.3 Sigma-Aldrich FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sigma-Aldrich FPR1 Antibody Product Portfolio
6.7.5 Sigma-Aldrich Recent Developments/Updates
6.8 BioLegend
6.8.1 BioLegend Company Information
6.8.2 BioLegend Description and Business Overview
6.8.3 BioLegend FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BioLegend FPR1 Antibody Product Portfolio
6.8.5 BioLegend Recent Developments/Updates
6.9 OriGene Technologies
6.9.1 OriGene Technologies Company Information
6.9.2 OriGene Technologies Description and Business Overview
6.9.3 OriGene Technologies FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 OriGene Technologies FPR1 Antibody Product Portfolio
6.9.5 OriGene Technologies Recent Developments/Updates
6.10 Boster Bio
6.10.1 Boster Bio Company Information
6.10.2 Boster Bio Description and Business Overview
6.10.3 Boster Bio FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Boster Bio FPR1 Antibody Product Portfolio
6.10.5 Boster Bio Recent Developments/Updates
6.11 Proteintech
6.11.1 Proteintech Company Information
6.11.2 Proteintech Description and Business Overview
6.11.3 Proteintech FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Proteintech FPR1 Antibody Product Portfolio
6.11.5 Proteintech Recent Developments/Updates
6.12 4a Biotech
6.12.1 4a Biotech Company Information
6.12.2 4a Biotech Description and Business Overview
6.12.3 4a Biotech FPR1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 4a Biotech FPR1 Antibody Product Portfolio
6.12.5 4a Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 FPR1 Antibody Industry Chain Analysis
7.2 FPR1 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 FPR1 Antibody Production Mode & Process Analysis
7.4 FPR1 Antibody Sales and Marketing
7.4.1 FPR1 Antibody Sales Channels
7.4.2 FPR1 Antibody Distributors
7.5 FPR1 Antibody Customer Analysis
8 FPR1 Antibody Market Dynamics
8.1 FPR1 Antibody Industry Trends
8.2 FPR1 Antibody Market Drivers
8.3 FPR1 Antibody Market Challenges
8.4 FPR1 Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global FPR1 Antibody Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global FPR1 Antibody Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global FPR1 Antibody Market Competitive Situation by Manufacturers in 2025
Table 4. Global FPR1 Antibody Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global FPR1 Antibody Sales Market Share by Manufacturers (2021–2026)
Table 6. Global FPR1 Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global FPR1 Antibody Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market FPR1 Antibody Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of FPR1 Antibody, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of FPR1 Antibody, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of FPR1 Antibody, Product Types and Applications
Table 12. Global Key Manufacturers of FPR1 Antibody, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global FPR1 Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on FPR1 Antibody Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global FPR1 Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global FPR1 Antibody Sales by Region (K Units), 2021–2026
Table 18. Global FPR1 Antibody Sales Market Share by Region (2021–2026)
Table 19. Global FPR1 Antibody Sales by Region (K Units), 2027–2032
Table 20. Global FPR1 Antibody Sales Market Share by Region (2027–2032)
Table 21. Global FPR1 Antibody Revenue by Region (US$ Million), 2021–2026
Table 22. Global FPR1 Antibody Revenue Market Share by Region (2021–2026)
Table 23. Global FPR1 Antibody Revenue by Region (US$ Million), 2027–2032
Table 24. Global FPR1 Antibody Revenue Market Share by Region (2027–2032)
Table 25. North America FPR1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America FPR1 Antibody Sales by Country (K Units), 2021–2026
Table 27. North America FPR1 Antibody Sales by Country (K Units), 2027–2032
Table 28. North America FPR1 Antibody Revenue by Country (US$ Million), 2021–2026
Table 29. North America FPR1 Antibody Revenue by Country (US$ Million), 2027–2032
Table 30. Europe FPR1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe FPR1 Antibody Sales by Country (K Units), 2021–2026
Table 32. Europe FPR1 Antibody Sales by Country (K Units), 2027–2032
Table 33. Europe FPR1 Antibody Revenue by Country (US$ Million), 2021–2026
Table 34. Europe FPR1 Antibody Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific FPR1 Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific FPR1 Antibody Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific FPR1 Antibody Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific FPR1 Antibody Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific FPR1 Antibody Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America FPR1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America FPR1 Antibody Sales by Country (K Units), 2021–2026
Table 42. Latin America FPR1 Antibody Sales by Country (K Units), 2027–2032
Table 43. Latin America FPR1 Antibody Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America FPR1 Antibody Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa FPR1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa FPR1 Antibody Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa FPR1 Antibody Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa FPR1 Antibody Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa FPR1 Antibody Revenue by Country (US$ Million), 2027–2032
Table 50. Global FPR1 Antibody Sales (K Units) by Type (2021–2026)
Table 51. Global FPR1 Antibody Sales (K Units) by Type (2027–2032)
Table 52. Global FPR1 Antibody Sales Market Share by Type (2021–2026)
Table 53. Global FPR1 Antibody Sales Market Share by Type (2027–2032)
Table 54. Global FPR1 Antibody Revenue (US$ Million) by Type (2021–2026)
Table 55. Global FPR1 Antibody Revenue (US$ Million) by Type (2027–2032)
Table 56. Global FPR1 Antibody Revenue Market Share by Type (2021–2026)
Table 57. Global FPR1 Antibody Revenue Market Share by Type (2027–2032)
Table 58. Global FPR1 Antibody Price (US$/Unit) by Type (2021–2026)
Table 59. Global FPR1 Antibody Price (US$/Unit) by Type (2027–2032)
Table 60. Global FPR1 Antibody Sales (K Units) by Application (2021–2026)
Table 61. Global FPR1 Antibody Sales (K Units) by Application (2027–2032)
Table 62. Global FPR1 Antibody Sales Market Share by Application (2021–2026)
Table 63. Global FPR1 Antibody Sales Market Share by Application (2027–2032)
Table 64. Global FPR1 Antibody Revenue (US$ Million) by Application (2021–2026)
Table 65. Global FPR1 Antibody Revenue (US$ Million) by Application (2027–2032)
Table 66. Global FPR1 Antibody Revenue Market Share by Application (2021–2026)
Table 67. Global FPR1 Antibody Revenue Market Share by Application (2027–2032)
Table 68. Global FPR1 Antibody Price (US$/Unit) by Application (2021–2026)
Table 69. Global FPR1 Antibody Price (US$/Unit) by Application (2027–2032)
Table 70. Abcam Company Information
Table 71. Abcam Description and Business Overview
Table 72. Abcam FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Abcam FPR1 Antibody Product
Table 74. Abcam Recent Developments/Updates
Table 75. Cell Signaling Technology Company Information
Table 76. Cell Signaling Technology Description and Business Overview
Table 77. Cell Signaling Technology FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Cell Signaling Technology FPR1 Antibody Product
Table 79. Cell Signaling Technology Recent Developments/Updates
Table 80. Santa Cruz Biotechnology Company Information
Table 81. Santa Cruz Biotechnology Description and Business Overview
Table 82. Santa Cruz Biotechnology FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Santa Cruz Biotechnology FPR1 Antibody Product
Table 84. Santa Cruz Biotechnology Recent Developments/Updates
Table 85. Novus Biologicals Company Information
Table 86. Novus Biologicals Description and Business Overview
Table 87. Novus Biologicals FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Novus Biologicals FPR1 Antibody Product
Table 89. Novus Biologicals Recent Developments/Updates
Table 90. Thermo Fisher Scientific Company Information
Table 91. Thermo Fisher Scientific Description and Business Overview
Table 92. Thermo Fisher Scientific FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Thermo Fisher Scientific FPR1 Antibody Product
Table 94. Thermo Fisher Scientific Recent Developments/Updates
Table 95. R&D Systems Company Information
Table 96. R&D Systems Description and Business Overview
Table 97. R&D Systems FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. R&D Systems FPR1 Antibody Product
Table 99. R&D Systems Recent Developments/Updates
Table 100. Sigma-Aldrich Company Information
Table 101. Sigma-Aldrich Description and Business Overview
Table 102. Sigma-Aldrich FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sigma-Aldrich FPR1 Antibody Product
Table 104. Sigma-Aldrich Recent Developments/Updates
Table 105. BioLegend Company Information
Table 106. BioLegend Description and Business Overview
Table 107. BioLegend FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. BioLegend FPR1 Antibody Product
Table 109. BioLegend Recent Developments/Updates
Table 110. OriGene Technologies Company Information
Table 111. OriGene Technologies Description and Business Overview
Table 112. OriGene Technologies FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. OriGene Technologies FPR1 Antibody Product
Table 114. OriGene Technologies Recent Developments/Updates
Table 115. Boster Bio Company Information
Table 116. Boster Bio Description and Business Overview
Table 117. Boster Bio FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Boster Bio FPR1 Antibody Product
Table 119. Boster Bio Recent Developments/Updates
Table 120. Proteintech Company Information
Table 121. Proteintech Description and Business Overview
Table 122. Proteintech FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Proteintech FPR1 Antibody Product
Table 124. Proteintech Recent Developments/Updates
Table 125. 4a Biotech Company Information
Table 126. 4a Biotech Description and Business Overview
Table 127. 4a Biotech FPR1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. 4a Biotech FPR1 Antibody Product
Table 129. 4a Biotech Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. FPR1 Antibody Distributors List
Table 133. FPR1 Antibody Customers List
Table 134. FPR1 Antibody Market Trends
Table 135. FPR1 Antibody Market Drivers
Table 136. FPR1 Antibody Market Challenges
Table 137. FPR1 Antibody Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of FPR1 Antibody
Figure 2. Global FPR1 Antibody Market Value by Type (US$ Million), 2021–2032
Figure 3. Global FPR1 Antibody Market Share by Type: 2025 & 2032
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Polyclonal Antibodies Product Picture
Figure 6. Global FPR1 Antibody Market Value by Application (US$ Million), 2021–2032
Figure 7. Global FPR1 Antibody Market Share by Application: 2025 & 2032
Figure 8. Immunology Research
Figure 9. Biomedical Research
Figure 10. Drug Discovery
Figure 11. Global FPR1 Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global FPR1 Antibody Market Size (US$ Million), 2021–2032
Figure 13. Global FPR1 Antibody Sales (K Units), 2021–2032
Figure 14. Global FPR1 Antibody Average Price (US$/Unit), 2021–2032
Figure 15. FPR1 Antibody Report Years Considered
Figure 16. FPR1 Antibody Sales Share by Manufacturers in 2025
Figure 17. Global FPR1 Antibody Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global FPR1 Antibody Players: Market Share by Revenue in FPR1 Antibody in 2025
Figure 19. FPR1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global FPR1 Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America FPR1 Antibody Sales Market Share by Country (2021–2032)
Figure 22. North America FPR1 Antibody Revenue Market Share by Country (2021–2032)
Figure 23. United States FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe FPR1 Antibody Sales Market Share by Country (2021–2032)
Figure 26. Europe FPR1 Antibody Revenue Market Share by Country (2021–2032)
Figure 27. Germany FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific FPR1 Antibody Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific FPR1 Antibody Revenue Market Share by Region (2021–2032)
Figure 34. China FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America FPR1 Antibody Sales Market Share by Country (2021–2032)
Figure 42. Latin America FPR1 Antibody Revenue Market Share by Country (2021–2032)
Figure 43. Mexico FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa FPR1 Antibody Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa FPR1 Antibody Revenue Market Share by Country (2021–2032)
Figure 49. Turkey FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE FPR1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of FPR1 Antibody by Type (2021–2032)
Figure 53. Global Revenue Market Share of FPR1 Antibody by Type (2021–2032)
Figure 54. Global FPR1 Antibody Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of FPR1 Antibody by Application (2021–2032)
Figure 56. Global Revenue Market Share of FPR1 Antibody by Application (2021–2032)
Figure 57. Global FPR1 Antibody Price (US$/Unit) by Application (2021–2032)
Figure 58. FPR1 Antibody Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
